This trial will compare how well two types of treatment, behavioral and pharmacologic, work when used alone or together to help people lose weight, improve cardiovascular risk factors, and function better socially after bariatric surgery.
1 Primary · 7 Secondary · Reporting Duration: From post-treatment (6-months) to the 12-month follow-up
Experimental Treatment
Non-Treatment Group
160 Total Participants · 4 Treatment Groups
Primary Treatment: Naltrexone and Bupropion Combination · Has Placebo Group · Phase 2 & 3
Age 18 - 70 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Texas | 100.0% |
18 - 65 | 100.0% |
Yale School of Medicine | 100.0% |
Met criteria | 100.0% |